AG
BSX icon

Ascent Group’s Boston Scientific BSX Stock Holding History

Ascent Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
37,895
+3,294
+10% +$179K 0.05% 302
2026
Q1 		$2.17M Sell
34,601
-1,168
-3% -$93.4K 0.08% 237
2025
Q4 		$3.41M Sell
35,769
-3,802
-10% -$373K 0.12% 174
2025
Q3 		$3.86M Sell
39,571
-5,577
-12% -$578K 0.14% 150
2025
Q2 		$4.85M Sell
45,148
-4,794
-10% -$485K 0.19% 113
2025
Q1 		$5.04M Buy
49,942
+34,645
+226% +$3.49M 0.22% 101
2024
Q4 		$1.37M Buy
15,297
+7,009
+85% +$617K 0.1% 237
2024
Q3 		$695K Buy
8,288
+808
+11% +$63.7K 0.05% 331
2024
Q2 		$576K Buy
7,480
+790
+12% +$57.8K 0.05% 336
2024
Q1 		$458K Sell
6,690
-72
-1% -$4.63K 0.04% 373
2023
Q4 		$439K Buy
6,762
+303
+5% +$16.2K 0.04% 367
2023
Q3 		$332K Buy
6,459
+541
+9% +$28.4K 0.04% 371
2023
Q2 		$299K Sell
5,918
-310
-5% -$16.2K 0.03% 375
2023
Q1 		$312K Buy
+6,228
New +$294K 0.03% 396

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ascent Group's BSX Position: Q2 2026 in Review

Ascent Group increased its Boston Scientific (BSX) stake by 9.5% in Q2 2026, buying an estimated $179K and bringing the position to 37,895 shares worth $1.62M. The position accounts for 0.05% of the portfolio, ranked #302.

Ascent Group first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.04M in Q1 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ascent Group held 37,895 shares of Boston Scientific worth $1.62M as of Q2 2026.
  • Ascent Group bought 3,294 Boston Scientific shares in Q2 2026, an estimated $179K.
  • Boston Scientific made up 0.05% of Ascent Group's portfolio in Q2 2026, its #302 holding.
  • Ascent Group first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Ascent Group's Boston Scientific position peaked at $5.04M in Q1 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.